Company: ERAS
Filing Date: 2025-03-20
Form Type: 10-K
Source: 0000950170-25-042682
Chunk: 323

Company: Erasca, Inc.
Filing Date: 2025-03-20
Form: 10-K
Item: Item 6
Chunk 323
---
 M.D., Ph.D. and the Registrant
     
    10-Q
     
    8/10/2023
     
    10.1

    10.9#
     
    Amended and Restated Employment Letter Agreement, dated July 9, 2021, by and between Ebun S. Garner and the Registrant
     
    S-1/A
     
    7/12/2021
     
    10.16

    10.10#
     
    Form of Indemnification Agreement for Directors and Officers
     
    S-1/A
     
    7/12/2021
     
    10.17

    10.11†
     
    Lease Agreement, dated September 29, 2020 by and between ARE-SD Region No. 23, LLC and the Registrant, as amended
     
    10-Q
     
    5/12/2022
     
    10.2

    10.12
     
    Open Market Sale Agreement, dated August 11, 2022, by and between Jefferies LLC and the Registrant
     
    S-3
     
    8/11/2022
     
    1.2

    10.13†
     
    Exclusive License Agreement, dated December 9, 2022 by and between Novartis Pharma AG and the Registrant
     
    10-K
     
    3/23/2023
     
    10.20

    10.14#
     
    Erasca, Inc. Non-Employee Director Compensation Program
     
    10-K
     
    3/27/2024
     
    10.18

    10.15†
     
    License Agreement, dated May 15, 2024, by and between Guangzhou Joyo Pharmatech Co., Ltd., and Erasca, Inc.
     
    10-Q
     
    8/12/2024
     
    10.1

    10.16†
     
    License Agreement, dated May 14, 2024, by and between Medshine Discovery Inc., and Erasca, Inc.
     
    10-Q
     
    8/12/2024